Science ❯ Medical Research ❯ Vaccine Development ❯ Clinical Trials

Safety Standards

FDA Approves LP.8.1 COVID Boosters, Limits Routine Use to Seniors and High-Risk Patients

Uncertainty over CDC guidance now clouds insurance coverage.

FDA Vaccine Chief Resigns, Citing Kennedy's 'Misinformation and Lies'